Aerosol Delivery Devices Market to Reach US$ 20,918.7 million by 2027 - PowerPoint PPT Presentation

About This Presentation

Aerosol Delivery Devices Market to Reach US$ 20,918.7 million by 2027


The global aerosol delivery devices market size is projected to grow from USD 14,392.4 million in 2020 to USD 20,918.7 million by 2027, registering a CAGR of 4.9% during the forecast period from 2021 to 2027. – PowerPoint PPT presentation

Number of Views:2
Slides: 13
Provided by: vipinmsg


Transcript and Presenter's Notes

Title: Aerosol Delivery Devices Market to Reach US$ 20,918.7 million by 2027

Market Research Report EXCLUSIVE EDITION
Global Aerosol Delivery Devices Market Report
Opportunities, and Forecast By 2030
Global Industry Analysis, Forecast and Trends,
Slalsville Consulling Píivale
Limiled www.maí
sales_at_maí 1 (646) 663-5829
Aerosol Delivery Devices Market
2020 Statsville Consulting Private Limited
Market Statsville Group (MSG) A part of
Statsville Consulting Private Limited American
Office 800 Third Avenue Suite A 1519 New
York, NY 10022 EMEA 1165 Budapest 16 Diósy
Lajos u. 24., Europe Asia-Pacific Office F-178
Subhash Marg C Scheme, Ashok Nagar, Jaipur,
Rajasthan, 302001 Discla
imer Any information and/or material provided by
Statsville Consulting Private Limited, including
any and all the analysis and/or research from
Market Statsville Group (MSG), is offered to a
selected group of customers in response to orders
for such information, material, analysis, and/or
research. As a customer of Statsville Consulting,
you acknowledge that our information, material,
and/or services are for your internal use only,
and not for any external use and/or
dissemination, or general publication, and/or
disclosure to any third parties. Any and all the
information and/or material provided by
Statsville Consulting are based on primary
interviews and/or secondary research, and are,
therefore, subject to fluctuation and variance.
Statsville Consulting takes no responsibility
for any incorrect information and/or material
supplied to us by sources we rely on, and no part
of our analysis or research may be given, lent,
resold, or disclosed to any third parties,
including non-customers, without explicit or
written permission from Statsville Consulting.
Unauthorized reproduction and/or transmission of
our information, material, analysis, and/or
research in any form and by any means, including
photocopying, mechanical/electronic recording,
or otherwise, without the explicit and written
permission of Statsville Consulting, is expressly
and clearly prohibited. Any use of the
information, material, analysis, and/or research
provided by Statsville Consulting is at your sole
risk you acknowledge that the information,
material, analysis, and/or research is provided
as is and that Statsville Consulting provides
no warranty of any kind, express or implied, with
regard to the information, material, analysis,
and/or research, including but not limited to,
merchantability and fitness for any purpose
and/or use. At the end, Statsville Consulting
will be responsible for the final decision of any
Market Statsville Group (MSG) partners with
companies and society to confront their essential
risks and challenges to capture the enormous
opportunities for them. MSG was initiated its
working in 2017, and since then, the brand is
moving to become a pioneer in business advisory
and market research services. Market Statsville
is the leading market research and strategy
builder with the depth and breadth of solutions
that perfectly suit your every need. MSG
provides solutions in a wide range of industry
verticals in the form of market sizing, analysis,
and incisive business insights. MSG experienced
research analysts are proficient at digging deep
and providing a variety of customizable data that
help you make decisions with clarity,
confidence, and impact. Market Statsville is your
global data intelligence partner for reliable
market research data, data gathering, and
analytical services. MSG also has an extensive
network of top-flight domestic and global
research personals around the world, enabling us
to provide high-quality worldwide research
solutions that cater to a well-established
company, government organizations, or a startup.
MSG's clients have the authority to work
directly with one or more of our researchers to
gather the most useful data knowledge and
analytical plan to formulate it in the actual
practice. Market Statsville Group believes that
to succeed, companies or individuals must blend
digital and human capabilities most efficiently.
MSG diverse and experienced global team of
business consultants and market researchers will
ensure the valuable reports for our clients
through digging in-depth market information and
functional expertise to continuously spark the
changes and real-time valuation of variation in
the market/industry. MSG works in a uniquely
collaborative model throughout the business
process across the globe to assist the client's
company with the most accurate information that
they are aiming for in the reports.
Our research is an optimum culmination of
secondary and primary research, with the latter
playing a major role. We also have an in-house
repository and access to a number of external
regional and global paid databases to help
address specific requirements of our clients. The
research process begins with a holistic
secondary research, followed by expert
interviews. The information gathered is then
comprehensively analyzed by our highly
experienced in-house research panel
Aerosol Delivery Devices Market 2021 Industry
Size, Regions, Emerging Trends, Growth Insights,
Development Scenario, Opportunities, and
Forecast By 2027
Aerosol Delivery Devices Market by Component
(Solution, Service), by Waste Type (Solid Waste,
Special Waste, E-Waste), by Smart Method
(Collection, Processing, Disposal, Energy
Recovery), by Application, by Region Global
Share and Forecast to 2027 Description The
global aerosol delivery devices market size is
projected to grow from USD 14,392.4 million
in 2020 to USD 20,918.7 million by 2027,
registering a CAGR of 4.9 during the forecast
period from 2021 to 2027. Aerosol delivery
devices are hand-held, portable drug distribution
devices. They consist of a suspension of liquid
or solid particles in a carrier gas, making it
feasible to treat lungs and non-respiratory
diseases. Different drugs are available for
aerosol drug delivery, such as dry powder,
solution, and suspension. It is the most
advanced drug administration in which aerosolized
drug is directly delivered to the lungs to offer
a systemic outcome. Aerosol delivery devices are
available in three categories dry powder
inhalers, nebulizers, and metered-dose inhalers.
Aerosol drug delivery is a natural treatment and
the easiest way to treat respiratory diseases
like asthma, cystic fibrosis, and COPD.
Furthermore, it is used to deliver insulin,
analgesic medications, and other drugs as
well. Increase in prevalence of COPD, asthma, and
other respiratory disorders, increase in smoking
population, ease of administration of the drug
with aerosol delivery devices, rise in demand for
metered-dose inhalers, technological
developments in inhaler devices, and rise in aged
population are the key factors that fuel the
growth of the global aerosol delivery devices
market. For instance, according to the WHO (World
Health Organization), in 2018, more than 339
million people were affected by asthma worldwide.
Request Sample Copy of this Report
rosol- delivery-devices-market Furthermore,
rise in the adoption of aerosol delivery devices
by patients, increase in patient awareness toward
inhalation therapy, the surge in preference of
pulmonary route of drug delivery, rise in
pollution levels and urbanization, increase in
incidences of preterm births and lifestyle
changes, and growth in the number of RD
activities to grow ideal inhalation therapy are
other factors that contribute toward the
development of the market. However,
complications and side-effects associated with
drug inhalation and the high cost associated
with nebulizers are expected to hinder the
market's growth. COVID-19 Impact on the Global
Aerosol Delivery Devices Coronavirus was
discovered in late December in Hubei province of
Wuhan city in China. The illness is caused by a
virus, namely, severe acute respiratory syndrome
coronavirus, which is spread from human to human.
After its discovery in Wuhan, the disease
speedily increased in other parts of the globe.
Moreover, this virus causes various symptoms in
a patient, ranging from common symptoms to
serious symptoms. On 11th March 2020, the WHO
(World Health Organization) assessed that
COVID-19 could be characterized as a pandemic. In
moreover, there are no drugs that are currently
licensed for COVID-19 treatment or prevention.
Thus, social distancing is observed as the most
important measure to stop the spread of this
disease. Furthermore, to maintain social
distancing, various countries across the world
have adopted nationwide lockdowns.
Global Aerosol Delivery Devices Market Dynamics
Drivers Increase in air pollution The rise in
air pollution due to smoke that comes out of the
vehicle and pollution caused by anthropogenic
sources is the primary factor attributed to the
increase in the prevalence of COPD and asthma.
Various research studies showed that asthma
symptoms deteriorate by air pollution. For
instance, a study conducted on young campers
suffering from moderate to severe asthma
displayed results that they were 40 more prone
to suffer from acute asthma incidents on days
when pollution level was as compared to average
pollution days. Two key air pollutants severely
trigger asthma ozone, which is found in smog,
and particulate matter found in smoke, haze, and
dust. Susceptibility of suffering from asthma
symptoms is on the rise at an alarming rate, as
the presence of both ozone and particulate
matter is on the increase in the air. Thus, a
surge in air pollution is expected to directly
lead to the rise in cases of asthma and COPD,
which, in turn, propel the market's
growth. Restraints High cost of asthma and COPD
treatments COPD and asthma treatments are
time-consuming and expensive, among which cost is
a significant concern that there is no one-time
solution for the problem. The sudden asthma
attack requires rescue inhalers, which are not
widely used in low-income countries, owing to
their higher costs. Globally, the most asthmatic
population is from low-income countries
therefore, the high cost of the treatment creates
a problem for them. According to the American
Thoracic Society 2019, health care costs for
asthma in the U.S. are estimated to total around
USD 300 billion over the next 20 years. In
addition, the yearly cost of asthma in the U.S.
is around USD 56 billion. Therefore, every year
increase in price for the treatment of asthma is
expected to hamper the market's growth.
  • Opportunities Growth opportunities in emerging
  • The rise of the aerosol delivery devices market
    is expected to be driven by opportunities in
    untapped, emerging markets, owing to the
    increase in the adoption of unhealthy lifestyles,
    the surge in urbanization, exposure to smoke
    chemicals, and a subsequent rise in the
    prevalence chronic obstructive pulmonary disease.
    For instance, according to the CDC (Centers for
    Disease Control and Prevention), in the U.S.,
    the overall prevalence of COPD was 6.2 in 2017.
    Moreover, according to the WHO, COPD is expected
    to be the third leading cause of death worldwide
    by 2030. The healthcare industry in developed
    countries is developing significantly, owing to
    increased demand for better-advanced
    manufacturing systems and significant investments
    by governments to improve healthcare
    infrastructure. Furthermore, emerging markets
    such as India and China are hubs for
    pharmaceutical and medical device companies,
    which provide lucrative opportunities for the
    market's growth.
  • Scope of the Report
  • The study categorizes the aerosol delivery
    devices market based on product, distribution
    channel, application, and regions.
  • Direct Purchase Report https//www.marketstatsvil
    2950 By Product Outlook (Revenue, USD Million,
  • Dry powder inhalers
  • Single-dose inhalers
  • Multi-dose inhalers
  • Metered-dose inhalers
  • Conventional pressurized inhalers,
  • Soft mist inhalers
  • Nebulizers
  • Jet nebulizers
  • Ultrasonic wave nebulizers
  • Vibrating mesh nebulizers

  • By Distribution Channel Outlook (Revenue, USD
    Million, 2017-2027)
  • Retail pharmacies
  • Hospital pharmacies
  • E-commerce
  • By Application Outlook (Revenue, USD Million,
  • Asthma
  • Chronic obstructive pulmonary disease
  • Cystic fibrosis
  • Non-respiratory diseases
  • Diabetes
  • Analgesia
  • Parkinsons disease
  • By Region Outlook (Sales, USD Million, 2017-2027)
  • North America (US, Canada, Mexico)
  • South America (Brazil, Argentina, Colombia, Peru,
    Rest of Latin America)
  • Europe (Germany, Italy, France, UK, Spain,
    Poland, Russia, Slovenia, Slovakia, Hungary,
  • Republic, Belgium, the Netherlands, Norway,
    Sweden, Denmark, Rest of Europe)
  • Asia Pacific (China, Japan, India, South Korea,
    Indonesia, Malaysia, Thailand, Vietnam, Myanmar,
    Cambodia, the Philippines, Singapore, Australia
    New Zealand, Rest of Asia Pacific)
  • The Middle East Africa (Saudi Arabia, UAE,
    South Africa, Northern Africa, Rest of MEA)

By product type, the metered-dose inhaler segment
is projected to account for the largest market
share The aerosol delivery devices market is
categorized into dry powder inhalers,
metered-dose inhalers, and nebulizers based on
product. The metered-dose inhaler segment is
expected to account for the largest revenue in
2020. It is projected to grow at a CAGR of 4.4
during the forecast period, owing to rise in
incidences of asthma, cystic fibrosis, and COPD,
the surge in patient awareness toward effective
advanced respiratory devices, and the launch of
effective products, which are tested under the
clinical trials by various companies to confirm
better therapeutic outcomes. Access full Report
Description, TOC, Table of Figure, Chart, etc
aerosol-delivery-devices- market MDIs deliver
medicine to patients in the form of mist. They
are used to treat numerous respiratory diseases
such as asthma, COPD, and cystic fibrosis. They
were developed in 1950 by Thiel Riker
laboratories, which provides bronchodilator drugs
formulations in pressurized containers with
greater convenience and reliable doses of
medication. This bronchodilator drug formulation
development led to the introduction of
proprietary pressurized metered-dose inhalers
(pMDIs). Metered-dose inhalers provide advantages
such as multiple-dose convenience, short
treatment time, reproducible emitted doses, no
requirement for drug preparation, and are less
prone to contamination. However, there are
several disadvantages of metered-dose inhalers,
including the need for hand-breath coordination
and reaction to propellants in some patients.
Asia Pacific accounts for the highest CAGR during
the forecast period Based on the region, the
global aerosol delivery devices market has been
segmented across North America, Asia-Pacific,
Europe, South America, and the Middle East
Africa. Asia-Pacific is analyzed across Japan,
China, India, Australia, South Korea, and the
Rest of Asia-Pacific. This region is growing at a
CAGR 6.4 share in the global aerosol delivery
devices market. The market development in this
region is attributable to a rise in the
geriatric population and a growth in the number
of smokers. For instance, according to Japan's
Internal Affairs and Communications Ministry,
Japan had around 35.57 million geriatric
population in 2018. Request For
Report Description https//www.marketstatsville.c
om/aerosol- delivery-devices-market
lhank You
Maíkel Slalsville Gíoup (MSG)
F-178 Subhash Maíg C Scheme, Ashok Nagaí,
Jaipuí, Rajaslhan, 302001 Phone 91 702 496
8807 Mail sales_at_maí
800 lhiíd Avenue Suile A 1519 New Yoík, NY
10022 Phone 1 (646) 663-5829 Mail
Write a Comment
User Comments (0)